Background Available incidence data for invasive salmonella disease in sub-Saharan Africa are scarce. Standardised, multicountry data are required to better understand the nature and burden of disease in Africa. We aimed to measure the adjusted incidence estimates of typhoid fever and invasive non-typhoidal salmonella (iNTS) disease in subSaharan Africa, and the antimicrobial susceptibility profi les of the causative agents.
Introduction
Salmonella infections are a major cause of global morbidity and mortality; however, substantial knowledge gaps exist with regards to the distribution and incidence of disease caused by Salmonella enterica serotype Typhi and invasive non-typhoidal salmonella (iNTS) disease in sub-Saharan Africa.
Before the Typhoid Fever Surveillance in Africa Program (TSAP), estimates of typhoid fever incidence data from Africa were available from four vaccine trials and one population-based study in Kenya. Other estimates of invasive salmonella infections originated from diff erent descriptions of bacteraemia in febrile patients in The Gambia, Malawi, Mozambique, and Kenya. These few, unstandardised, published data are not suffi cient for understanding the burden of the disease in sub-Saharan Africa.
In 2008, WHO expressed the necessity for more epidemiological information to estimate the incidence and antimicrobial susceptibility of invasive salmonella disease. Consequently, in January, 2009, the International Vaccine Institute (Seoul, South Korea) and the Kenya Medical Research Institute (Kilifi , Kenya) co-hosted a meeting with fi ve other international institutions and 28 investigators from 14 research sites across sub-Saharan Africa. The purpose of the meeting was to review existing data on invasive salmonella infections in sub-Saharan Africa and surveillance infrastructure from sites, and to discuss the way forward to investigate invasive salmonella in the African region. These 28 investigators and the fi ve international institutions presented their data on invasive bacterial disease, focusing on invasive salmonellosis.
The data indicated the presence of typhoid fever and iNTS disease; however, the studies were not standardised in design, data collection, and laboratory techniques. The meeting concluded that unless standardised methods of data collection and diagnostic procedure were used across countries, and patterns of health-care utilisation were understood and accounted for, the real disease burden of invasive salmonella infections in the region would remain unclear. As a result, a consortium was established and members agreed to form a network of surveillance sites in sub-Saharan Africa in areas with previous reports of cases of typhoid fever.
The TSAP was created to address the knowledge gaps on the incidence and antimicrobial resistance patterns of invasive salmonella infections at diff erent countries with previous reports of typhoid fever cases in sub-Saharan Africa. TSAP created a network of 13 surveillance sites across ten countries, and implemented cross-sectional studies to investigate the health-care-seeking behaviour of the populations under surveillance.
Added value of this study
Original data collected in TSAP represent the most comprehensive standardised analysis done in sub-Saharan Africa of the incidence and antimicrobial resistance patterns of invasive salmonella infections. The results describe the incidence estimated, adjusted by health-care-seeking behaviour, and antimicrobial susceptibility of typhoid fever and iNTS diseases from 13 sites in ten sub-Saharan Africa countries. For typhoid fever disease, we estimate that the overall incidence is two to three times higher than a previous estimate (10-100 cases per 100 000 people), and is in some settings similar to data from Asia, where the burden is known to be very high. The data also revealed that children aged 2-14 years bear the greatest burden of the disease. For iNTS disease, the data also refl ect a high incidence, especially in young children, and in specifi c sites (Ghana) the incidence could be more than fi ve times that previously estimated.
Implications of all the available evidence
The results of this study underscore the need for preventive measures, including vaccines, improved sanitation and hygiene, malaria control, antiretroviral therapy programmes, and improved nutrition. The results also emphasise that the implementation of eff ective antimicrobials might be impaired by the presence and potential increase of drug-resistance salmonella strains in the region. The advent of typhoid conjugate vaccines might provide more powerful tools to control typhoid fever; the fi rst vaccine, which was manufactured in India, has already been submitted to WHO for prequalifi cation. Data from this study will be included in the GAVI Alliance review of potential subsidies for typhoid fever vaccines in 2017; their recommendation will be crucial for the deployment of these vaccines. Hence, an urgent need exists to understand the pragmatic aspects of vaccine targeting and delivery, particularly given the burden of disease in children, the associated risk factors, and the focal nature of the disease. Further assessment of the incidence in infants (0-5 months vs 6-11 months) and data on severe typhoid fever or iNTS, including mortality, is crucial to determine the potential eff ect of future vaccines. Our follow-on study-Severe Typhoid in Africa (SETA)-which investigates severe typhoid burden, is underway. locations where typhoid fever had been previously reported. This network formed the Typhoid Fever Surveillance in Africa Program (TSAP) and served as a platform to implement standardised surveillance of febrile illness and cross-sectional studies to investigate the health-care-seeking behaviour of the surveyed populations. [10] [11] [12] Here, we present the adjusted incidence estimates of typhoid fever and iNTS disease and the antimicrobial susceptibility profi les of the causative agents at the 13 selected surveillance sites.
Methods

Study design, site selection, and participants
We used a multicentre, population-based, prospective surveillance study design. Selection of the surveillance sites in sub-Saharan Africa was not random; locations were eligible if they had evidence of previous typhoid fever, a laboratory infrastructure suitable for blood culture, an onsite health-care facility, and staff experienced in micro biological laboratory research. 10 13 sites in ten countries were selected (fi gure 1), four of which already had established surveillance systems: Pietermaritzburg, South Africa; Asante Akim North, Ghana; Moshi Urban District and Moshi Rural District, Tanzania; and Kibera, Kenya. Four sites were part of the International Network for the Demographic Evaluation of Populations and Their Health (INDEPTH): Polesgo and Nioko II, Burkina Faso; Butajira, Ethiopia; and Bandim, Guinea-Bissau. These sites had functional Health and Demographic Surveillance Systems (HDSS) in place. 13 Additional surveillance sites were Isotry and Imerintsiatosika, Madagascar; Pikine, Senegal; and East Wad Medani, Sudan. The surveillance system in Kibera was established before TSAP with an active, populationbased surveillance component. Home visits were done once every 2 weeks to screen for febrile patients and encourage visits to the affi liated health-care facility. Active surveillance in Kibera was continued throughout TSAP. All other sites implemented passive surveillance. 10 The ethics committees of all collaborating institutions and the International Vaccine Institute (Seoul, South Korea) approved the study protocol. The catchment area for each site was determined through health-care facility records and through accessible administrative and demographic data. 11 We determined the population of each catchment area using the latest census or the INDEPTH database. We categorised sites as urban, rural, or other using setting classifi cations at each site. Surveillance was implemented in each study location for a period of at least 12 months and recruitment occurred at primary, secondary, and tertiary health-care facilities.
Recruitment was open to outpatients and inpatients who visited any of the health-care facilities participating in TSAP, who resided within the catchment area and presented with tympanic (≥38·0°C) or axillary temperature (≥37·5°C). Inpatients with a reported history of fever for 72 h or longer were excluded, as were patients with residence outside of the catchment area. Asante Akim North recruited children younger than age 15 years only; other sites recruited patients of all ages. Written informed consent preceded recruitment and clinical appraisal forms were completed for all participants.
Laboratory procedures
We standardised laboratory, quality control, and blood sample collection procedures across sites. 10 Blood (5-10 mL for adults; 1-3 mL for children) was inoculated into aerobic blood culture bottles and incubated in an automated blood culture system (BD BACTEC, BectonDickinson, USA, or BacT/ALERT, BioMérieux, France), with the exception of Sudan, where manual culturing with daily subculturing for up to 5 days was instituted. Gram staining and bacterial identifi cation were done with standard microbiological techniques.
14 Quality control of preanalytical processes included time and temperature control measures, during which every blood culture bottle was collected, transported, and placed into the incubator. Quality control of analytical processes included sterility and function control of culture media, controls of biochemical reactions, and antimicrobial susceptibility testing. For the quality control of manual culturing in Sudan, additionally, blood culture bottles were inoculated weekly with a suspension containing Escherichia coli or Staphylococcus aureus references. Inoculated blood culture bottles were incubated overnight and verifi ed for growth by subculture.
Contaminants were defi ned as organisms not typically associated with bloodstream infections; these included non-pathogens and those more commonly associated with commensal skin microbiota, including coagulasenegative Staphylococci, Bacillus spp, and Micrococcus spp. Antimicrobial susceptibility testing was done by disc diff usion according to Clinical and Laboratory Standards Institute 15 standards for ampicillin, amoxicillin-clavulanic acid, chloramphenicol, co-trimoxazole, ceftriaxone, and ciprofl oxacin. Multidrug resistance was defi ned as resistance to ampicillin or amoxicillin-clavulanic acid, chloramphenicol, and co-trimoxazole. Isolates with intermediate susceptibility were classifi ed as resistant. Malaria blood smears were routinely done, except in South Africa. In Ethiopia, rapid diagnostic tests (SD BIOLINE Malaria Ag Pf/Pv, SD Standard Diagnostics, Yongin, South Korea) were used in addition to routine malaria blood smears. Visits to health-care facilities and recruitment of patients during surveillance period at each site NA=not available. *Data on health facility visits were collected retrospectively, after completion of surveillance period. Diagnosis of febrile illnesses was used at sites when temperature of patients was not recorded. †Number estimated by the proportion of the population under demographic surveillance at each respective site. ‡In Tanzania, before Nov 11, 2011, every fi fth eligible patient was recruited; from Nov 11, 2011, every second eligible patient was recruited. This recruitment pattern was applied to this number. 
Health-care utilisation survey and person-years of observation calculation
The health-care-seeking behaviour of the populations under surveillance was investigated with the assumption that access to the TSAP health-care facility was nonuniform throughout the population. 16, 17 A standardised and pretested health-care utilisation survey was implemented in a representative sample of households randomly selected from each study area. 11 We investigated health-care-seeking behaviour in cases of self-reported fever lasting less than 3 days. The fi rst choice of healthcare facility in cases of fever was categorised by agestratifi ed groups and used to calculate the proportion of individuals from the catchment population who visited this TSAP health-care facility. This proportion constituted an adjustment factor to correct incidences. The time at risk in person-years of observation (PYO) stratifi ed by age was calculated using the adjusted population. In HDSS sites, each resident contributed to PYO for the time present in the study area during the recruitment period. In non-HDSS sites, we calculated PYO by projecting the catchment population from the start to the end of the study recruitment period, and multiplied the calculated average population by the number of years of surveillance duration.
Statistical analysis
We established a multicountry database using FoxPro software. We excluded patients from the analysis who were recruited during pilot testing, failed to meet inclusion criteria, or had incomplete laboratory results. We estimated incidences per 100 000 PYO. Confi rmed invasive salmonella cases, stratifi ed by age group (0-1 years, 2-4 years, 5-14 years, and ≥15 years), were adjusted by the specifi c age-group recruitment proportion. We calculated this proportion by dividing the number of patients with complete data (numerator) by the total number of patients in the study area who had been diagnosed with a febrile illness at a recruitment facility during the surveillance period (denominator). We used health-care facility records, reviewed at the end of the surveillance activities, to estimate the number of patients diagnosed with a febrile illness. The catchment population in PYO, adjusted by health-care-seeking behaviour, was used as the denominator in crude and adjusted incidence rates (AIR).
The 95% CI for AIR was derived on the log-scale and exponentiated. We used the error factor (exp[1·96/√adjusted cases]) to calculate the lower (adjusted rate/error factor) and upper (adjusted rate × error factor) 95% CIs. At the sites in Senegal, Ethiopia, and South Africa, incomplete health-care facility records did not allow for the estimation of the recruitment proportion and calculation of AIRs; for these sites we present crude rates. AIRs for typhoid fever and iNTS were assessed for all other sites. Diff erences in proportions of blood cultures positive for a pathogen between study years were assessed with the χ² test (SAS, version 9.3). Sudan were provided by the Statistics Department, Population Center, University of Gezira, Sudan, and correspond to year 2008. † †Population data for South Africa were provided by the Statistics Department in South Africa and corresponds to the 2011 census. ‡ ‡Population data for Tanzania were provided by the National Bureau of Statistics and correspond to the 2012 population and housing census. § §Patients who met inclusion criteria, consented to take part in the study, and had a blood culture taken and a documented blood culture result. ¶ ¶Recruitment health-care facility providing outpatient services only. ||||Positive for non-contaminant isolates. ***Denominator diff ers from all blood cultures analysed because of missing values. Malaria results are based on blood smears, except for the site in Butajira (52% of patients positive for malaria were diagnosed with malaria rapid tests). Role of the funding source
The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication.
Results
Between March 1, 2010, and Jan 31, 2014, we recruited 13 558 patients from 13 sites who met the inclusion criteria and resided in the catchment areas (fi gures 1, 2). We excluded data from 127 (1%) patients because of incomplete laboratory results; data from 13 431 patients were analysed, and 8582 patients (64%) were younger than 15 years ( (table 2) . S Paratyphi A (three isolates) was isolated in Senegal only.
Among age groups of children younger than 15 years, the highest AIR for typhoid fever was observed in children aged 2-4 years from Polesgo, Asante Akim North, Moshi Urban District, and Kibera, and in children aged 5-14 years from Kibera and Polesgo (table 2). The AIR for typhoid fever in adults (aged ≥15 years) was less than 70 per 100 000 PYO at all sites except Moshi Urban District, Kibera, and Polesgo (table 2) .
iNTS organisms were more frequently isolated from infants (0-1 years) or children aged 2-4 years than from adults (table 2), except for the sites in Pikine, Moshi Rural District, and Kibera. The AIR for iNTS among children aged 2-4 years was highest in Nioko II, Polesgo, and Asante Akim North. The AIR for iNTS in children younger than 15 years was less than 100 per 100 000 PYO in Kibera, Imerintsiatosika, and in both sites in Tanzania. No iNTS was isolated from sites in Sudan, South Africa, Ethiopia, and Isotry.
The antimicrobial susceptibility profi les of S Typhi and iNTS isolates diff ered between sites (table 3) . Overall, 47% of S Typhi isolates and 48% of iNTS isolates were multidrug resistant. Most multidrug-resistant S Typhi isolates were obtained at the sites in Kenya, Ghana, and Tanzania (both sites combined). Multidrugresistant iNTS isolates were isolated at the sites in Burkina Faso (both combined), Ghana, GuineaBissau, and Kenya (table 3). S Typhi isolates that had reduced ciprofl oxacin susceptibility were cultured in Kenya and South Africa, only; one ciprofl oxacinresistant S Paratyphi A organism was isolated in Senegal. Ciprofl oxacin-resistant iNTS was similarly uncommon, isolated only in Burkino Faso (once at the Nioko II site) and in Ghana. One iNTS isolate in Kenya was resistant to ceftriaxone (table 3) .
Discussion
This study identifi ed Salmonella as a major cause of invasive bacterial febrile illness across sub-Saharan Africa, aff ecting children aged 2-14 years rather than adults, and arising in both high-population and lowpopulation density settings. Other major causes of invasive bacterial febrile illnesses varied by country; E coli and S aureus were the most frequent nonSalmonella pathogens isolated from blood.
Results from previous studies 18, 19 suggest that typhoid fever in some sub-Saharan Africa settings occurs predominately in urban settlements with highpopulation densities, and that disease incidence could have been overestimated by the use of the Widal test. Our study, done using a standardised protocol in both urban and rural settings, indicated high incidences of typhoid fever and iNTS in areas with high-population and low-population densities. Separate analyses done at the Ghana site confi rmed this observation and revealed a higher disease incidence in children living in rural areas than in those living in urban areas. 20 Furthermore, we observed variable incidences of typhoid fever and iNTS among neighbouring populations in Burkina Faso, and in the same populations in Kenya and Ghana in consecutive years, indicating a focal nature and a fl uctuating burden of iNTS disease.
A previous global estimate of the burden of typhoid fever indicated that south-central and east-central Asia had the highest incidences of typhoid fever with more than 100 cases per 100 000 people annually; Africa was estimated to have a medium incidence (10-100 cases per 100 000). 1 The AIR for typhoid fever estimated in our Study population was adjusted for health-seeking behaviour and crude cases were adjusted for recruitment proportion (number of patients analysed divided by number of patients with febrile illness from study area who visited a recruitment health facility, multiplied by 100). iNTS=invasive non-typhoidal salmonella. NA=not available. PYO=person-years of observation. *Recruitment portion was not available for each age strata. Broader values were applied to each stratum. †Target population for surveillance activities in Ghana included patients younger than 15 years of age; patients aged 15 years or older were not recruited. ‡Three Salmonella Paratyphi A were identifi ed at this site, but are not included in this table. §No salmonella was isolated in
Sudan. Missing data on recruitment patterns in Senegal, Ethiopia, and South Africa did not allow calculation of adjusted incidences. Crude rates are presented. ¶This proportion applies to age group <1 year, and it was used to adjust the study population by health-seeking behaviour. ||This proportion applies to age group 1-4 years, and it was used to adjust the study population by health-seeking behaviour. The adjusted populations in age groups <1 year and 1-4 years were added to estimate the total adjusted population age group 0-4 years. Subsequently, the percentage of children <2 years reported by the 2012 national census was applied to derive age groups 0-1 years and 2-4 years. **Crude cases have been adjusted for recruitment pattern unique to the site in Tanzania: before Nov 11, 2011, every fi fth eligible patient was recruited; from Nov 11, 2011, every second eligible patient was recruited. Adjusted cases (presented inside parentheses) were used to calculate crude rate. † †Active population mobilisation was done, in addition to passive surveillance. Four sites had an overall AIR for typhoid fever of more than 100 per 100 000 PYO, fi ve sites had an AIR for typhoid fever of more than 100 per 100 000 PYO in children younger than 15 years, and six sites had an AIR for typhoid fever of more than 100 per 100 000 PYO in at least one age group. Similar to the Diseases of the Most Impoverished programme done in Asia, 21 our results show that children aged 2-14 years bear the greatest burden of typhoid fever. Notably, our data indicate that the AIR for typhoid fever at TSAP sites was equal to or even greater than incidences reported in fi ve Asian countries in the early 2000s. 21, 22 For iNTS disease, we observed an AIR equal or higher than previously estimated and a bimodal age distribution with very young children and adults being the key age group for symptomatic infection. 2 This age distribution diff ered from that observed for typhoid fever, in which children aged 2-14 years were the most aff ected, and emphasises substantial diff erences in the epidemiology of typhoid fever and iNTS disease. Malaria, malnutrition, and HIV infections have been reported to be associated with iNTS disease in Africa. 23 At TSAP sites, a higher AIR for iNTS was observed in children with a malaria positivity rate of 30% or more than in those with a lower positivity rate; this observation was confi rmed in a separate analysis. 24 Results of our study identifi ed a high prevalence of resistance against fi rst-line antimicrobials in both S Typhi and iNTS infections. Reduced susceptibility to ciprofl oxacin was identifi ed in S Typhi from Kibera and Pietermaritzburg. Multidrug-resistant iNTS isolates were isolated at several sites and have been isolated in sub-Saharan Africa previously. 18, 25, 26 Furthermore, a single iNTS isolate from Kibera showed resistance to ceftriaxone. Genomic analyses 27 have described the spread of S Typhi haplotype H58 into Africa, a multidrugresistant strain associated with reduced ciprofl oxacin susceptibility. The susceptibility patterns observed in our study are concerning, particularly because some anti microbial-resistant S Typhi can have a selective fi tness advantage. 28 Concerted measures are needed to monitor the emergence of fl uoroquinolone-resistant Salmonella. [29] [30] [31] [32] We made all eff orts to minimise bias; however, our study has some limitations. First, we did not adjust the disease incidences for blood culture sensitivity, which is approximately 40-60% of bone marrow culture. [33] [34] [35] [36] [37] This correction factor is inconsistently applied in studies and, if applied here, the incidences presented would double. The restricted sensitivity of blood culture to detect Salmonella pathogens applies to other bacterial pathogens as well-ie, S pneumoniae and Haemophilus infl uenzae type b-however, those are universally recognised as important infections for which vaccines are cost-eff ective, and vaccination programmes have been established. Second, our results represent incidence in sites selected because of their previous reports on typhoid fever. The site selection strategy limits the generalisability of the AIR to other locations and might result in the reduced detection of iNTS disease. Third, given the vast number of patients (and restricted diagnostics capacity), not every patient with a history of fever was enrolled-eg, at sites where inpatients were recruited, patients with a fever for 72 h or longer were excluded to minimise the inclusion of patients pretreated with antimicrobials and to maximise blood culture yield. Fourth, the proportion of the catchment population using the TSAP health-care facilities for febrile illness was low in some sites, and antimicrobial treatment before blood collection and its potential eff ect on blood culture sensitivity were not assessed. Fifth, the classifi cation of the settings as either urban, rural, semi-urban, or urban-slum refl ects the classifi cation commonly used at each site and does not refer to a standard defi nition; instead, the population density of each site is presented to make setting comparisons. Sixth, sites with no previous experience of blood collection for blood culture assessment had a higher incidence of contamination than sites with previous experience of blood collection (South Africa, Ghana, Tanzania, and Kenya); these incidences might have led to errors in clinical interpretation and uncertainty to distinguish between clinically signifi cant bacteraemia and contamination. Available isolates and blood samples collected from participants were PCR tested at the reference lab to minimise misclassifi cation of isolated organisms. Seventh, the site in Ghana recruited only children younger than 15 years and the proportion of recruited inpatients varied greatly across all sites. Finally, data on disease severity, complications, mortality, and HIV status were not assessed because these were not primary study objectives. Despite these limitations, this multisite study, the largest study of typhoid fever and iNTS done across sub-Saharan Africa to date, provides the most current and accurate incidence fi gures for these major infectious diseases across the continent and has substantial implications for their control. We surmise that the incidence of invasive salmonella infections among children in sub-Saharan Africa is much higher than previously estimated, underscoring the need for preventive measures. Therefore, until access to safe drinking water and improved sanitation is greatly expanded, the prevention of typhoid fever will require immunisation and eff ective treatment options. 38 The advent of new typhoid fever conjugate vaccines might provide more powerful tools for disease control; the fi rst typhoid fever conjugate vaccine (Bharat Biotech, Hyderabad) has been submitted to WHO for prequalifi cation. Data from TSAP will be incorporated into the GAVI Alliances' review of potential subsidies for typhoid fever vaccines in 2017; their recommendation will be crucial for deployment of these vaccines. Hence, the need to understand the pragmatic aspects of vaccine targeting and delivery is pressing, particularly given the burden of disease in children, the associated risk factors, and the focal and unpredictable nature of the disease.
Similarly, in the absence of vaccines targeting iNTS disease, prevention will require a major investment in infrastructure for diagnosis and eff ective treatment of iNTS disease. When appropriate diagnosis and treatment are available, the use of eff ective antimicrobials might be impaired by the presence and potential increase of multidrug-resistant salmonella. Further assessment of incidences in infants (0-5 months vs 6-11 months) and data on severe typhoid fever or iNTS, including mortality, is crucial to determine the potential eff ect of future vaccines. We are currently undertaking a follow-on study-Severe Typhoid in Africa (SETA)-which investigates severe typhoid burden.
We conclude that typhoid fever and iNTS disease are major agents of invasive bloodstream infections in urban and rural locations, aff ecting children more commonly than adults across sub-Saharan Africa. Immunisation of high-risk age groups with existing and new vaccines should be a priority. The next generation of epidemiological studies in sub-Saharan Africa needs to provide better data regarding the severity and mortality of typhoid fever and iNTS to guide the introduction of new typhoid and iNTS vaccines. Lastly, the accelerated development and introduction of iNTS vaccines needs to become a fundamental goal on the global health agenda.
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